Back to Trades
Sell4
Kiniksa Pharmaceuticals International, plc
KNSA
Total Value
$1.1M
Net $772.3K sold
Sales
$772.3K
2 transactions
Company Information
- Company Name
- Kiniksa Pharmaceuticals International, plc
- Ticker Symbol
- KNSA
- CIK
- 0001730430
Insider Information
- Name
- Ragosa Mark
- Role
- Insider
- Location
- LONDON, X0
Filing Details
- Filing Date
- Feb 11, 2026
- Transaction Date
- Feb 9, 2026
- Accession Number
- 0001835458-26-000004
- Form Type
- 4
- Net Trading Amount
- -$772.3K
Non-Derivative Transactions
| Date | Security | Shares | Price | Type | Value |
|---|---|---|---|---|---|
| Feb 9, 2026 | Class A Ordinary Share | 8,374 | $12.97 | Exercise | $108.6K |
| Feb 9, 2026 | Class A Ordinary Share | 2,471 | $16.90 | Exercise | $41.8K |
| Feb 9, 2026 | Class A Ordinary Share | 9,114 | $42.85 | Sale | $390.5K |
| Feb 9, 2026 | Class A Ordinary Share | 8,731 | $43.72 | Sale | $381.7K |
Derivative Transactions
| Date | Security | Shares | Exercise Price | Type | Value |
|---|---|---|---|---|---|
| Feb 9, 2026 | Derivative | 8,374 | $12.97 | Exercise | $108.6K |
| Feb 9, 2026 | Derivative | 2,471 | $16.90 | Exercise | $41.8K |
Footnotes
- (F1)This transaction was effected pursuant to a 10b5-1 plan executed by the reporting person on August 14, 2025.
- (F2)This transaction was executed in multiple trades through a broker-dealer at prices ranging between $42.35 and $43.345. The price reported in this column reflects a weighted average sales price. Upon request, the reporting person will provide to the SEC staff fullinformation regarding the number of Shares sold at each price.
- (F3)This transaction was executed in multiple trades through a broker-dealer at prices ranging between $43.35 and $44.18. The price reported in this column reflects a weighted average sales price. Upon request, the reporting person will provide to the SEC staff fullinformation regarding the number of Shares sold at each price.
- (F4)The option is fully vested and exercisable.